Form 8-K - Current report:
SEC Accession No. 0000950170-22-011471
Filing Date
2022-06-10
Accepted
2022-06-10 16:02:28
Documents
12
Period of Report
2022-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K prds-20220608.htm   iXBRL 8-K 75014
  Complete submission text file 0000950170-22-011471.txt   201212

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20220608_lab.xml EX-101.LAB 14452
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20220608.xsd EX-101.SCH 2467
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20220608_pre.xml EX-101.PRE 11807
6 EXTRACTED XBRL INSTANCE DOCUMENT prds-20220608_htm.xml XML 5068
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40067 | Film No.: 221008803
SIC: 2834 Pharmaceutical Preparations